Medadvisor Ltd
ASX:MDR
Relative Value
The Relative Value of one MDR stock under the Base Case scenario is 0.448 AUD. Compared to the current market price of 0.295 AUD, Medadvisor Ltd is Undervalued by 34%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
MDR Competitors Multiples
Medadvisor Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
AU |
Medadvisor Ltd
ASX:MDR
|
162.3m AUD | 1.5 | -18 | -26.6 | -26.6 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 13.7 | 61.6 | 61.4 | 66.1 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | ||
JP |
M3 Inc
TSE:2413
|
1.3T JPY | 5.4 | 27.5 | 14.6 | 16.4 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 78.1 | 163.9 | 112.7 | 112.7 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | 11.2 | -331.8 | -175.3 | -162.9 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9.5 | 32.2 | 21.5 | 22.9 | ||
SE |
Sectra AB
STO:SECT B
|
42.7B SEK | 26.1 | 100.6 | -66.2 | -66.2 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -22.1 | 26.1 | 277.7 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.8 | -319.5 | 34.1 | -111.3 |